Glucocorticoid-induced osteoporosis: mechanisms, time- and dose-dependent effects, and clinical management: a narrative review
Osteologie · 2026-08-28
DOI: 10.1055/a-2917-1844 ↗Abstract
Abstract Glucocorticoids (GCs) are effective anti-inflammatory and immunosuppressive agents that are widely used in clinical practice to treat various diseases. However, their therapeutic benefits are accompanied by well-recognized adverse effects. The detrimental effects of GCs on bone health are well known, such as glucocorticoid-induced osteoporosis and fractures. It is a worldwide critical health issue to explore appropriate therapeutic regimens, especially the duration and dosage of glucocorticoid use, so as to achieve a balance between maintaining efficacy and avoiding bone damage. This review summarizes recent advances in understanding the time-dependent and dose-dependent effects of glucocorticoid treatment across different disease settings, with the aim of providing insights that may assist clinicians in developing safer and more individualized glucocorticoid treatment strategies.
EUVIMED